The Rise of the CRO in Drug Discovery and Development
Podcast Jan 27, 2017 | By Jack Rudd, Senior Editor for Technology Networks
In this episode, we are going to explore the growing market for contract services in drug discovery and development.
A number of R&D trends such as precision-based medicines and immunotherapies for smaller populations and treatments for rare diseases are driving this growth. Aside from the exorbitant costs tied to development, these treatments require advanced and integrated expertise. In an effort to contain costs and shorten development timelines, pharma and biopharma firms increasingly outsource many services associated with the development of today’s complex therapies into the hands of CROs.
Salford Lung Study - The First Real World Clinical TrialPodcast
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.READ MORE